CytoSorbents Corporation (CTSO)

[caesare74]

Correct Techxen. Key trigger for more sales here in Europe but also other countries, is mainly the "medical code", thus a doctore can directly/automatically process the bill with the health insurance companies. Without the "medical code", the use of filters is low because the administration work to get the reimbursement is (too) high. Even if a doctore sees all the advantages using the CTSO filters, he rather goes for a traditional product (antibiotics) having a medical code. I spoke to a doctore here in Switzerland who used some time ago the filter. For trial purposes. But a further use is planned in Jan. 2019 when Switzerland gets the medical code for the CTSO filter. In Switzerland, Cytosorb has one direct sales, like in Germany. Although, Cytosorb has a partnerhsip agreement with Fresenius Medical, Cytosorb Switzerland has a direct sales. Outside of Germany, Switzerland, Austria (not yet a direct sales), Cytosorb will build direct sales. Partner business, e.g.Fresnenius, is fine, but very slow. As said, a partnership with a big pharma will be a key trigger as well to speed up the sales.